Abstract
Ventilator associated pneumonia remains a cause of significant morbidity and mortality in Intensive Care patients despite advances in knowledge and technology. The presence of an endotracheal tube bypassing the normal airway barriers, oropharyngeal bacterial colonisation, patient position and repetitive micro-aspiration tip the host-pathogen relationship in favour of the pathogen and promote lung infection in a time-dependent manner. Defending the lung against microbial invasion and infection is a multiplicity of innate and adaptive immune mechanisms, which can identify and eliminate potential pathogens. These defence mechanisms include the ability to recognise pathogens through cell-surface receptors, antimicrobial peptides and proteins, pro and anti-inflammatory mediators and factors related to the coagulant state of the lung fluid. The mechanisms are characterised by their complexity, their remarkable degree of redundancy and effectiveness.
Keywords: Inspired Gases, Klebsiella pneumoniae, phagocytic cells, Cathelicidins, peptide antibiotics, Defensins
Current Respiratory Medicine Reviews
Title: Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia
Volume: 2 Issue: 3
Author(s): Matt Wise, Josephine Lightowler and Christopher Garrard
Affiliation:
Keywords: Inspired Gases, Klebsiella pneumoniae, phagocytic cells, Cathelicidins, peptide antibiotics, Defensins
Abstract: Ventilator associated pneumonia remains a cause of significant morbidity and mortality in Intensive Care patients despite advances in knowledge and technology. The presence of an endotracheal tube bypassing the normal airway barriers, oropharyngeal bacterial colonisation, patient position and repetitive micro-aspiration tip the host-pathogen relationship in favour of the pathogen and promote lung infection in a time-dependent manner. Defending the lung against microbial invasion and infection is a multiplicity of innate and adaptive immune mechanisms, which can identify and eliminate potential pathogens. These defence mechanisms include the ability to recognise pathogens through cell-surface receptors, antimicrobial peptides and proteins, pro and anti-inflammatory mediators and factors related to the coagulant state of the lung fluid. The mechanisms are characterised by their complexity, their remarkable degree of redundancy and effectiveness.
Export Options
About this article
Cite this article as:
Wise Matt, Lightowler Josephine and Garrard Christopher, Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778018971
DOI https://dx.doi.org/10.2174/157339806778018971 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design Cancer Stem-Cells Patents in the Context of their Therapeutic Purposes: Exploring the Latest Trends (2011-2015)
Recent Patents on Regenerative Medicine A Dual Role for Sirtuin 1 in Tumorigenesis
Current Pharmaceutical Design Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward
Anti-Cancer Agents in Medicinal Chemistry Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Adult Neural Stem Cell Therapy: Expansion In Vitro, Tracking In Vivo and Clinical Transplantation
Current Drug Targets Bioinformatic Analysis of HIV-1 Entry and Pathogenesis
Current HIV Research Recent Advances of Silver Nanoparticles in Cancer Diagnosis and Treatment
Anti-Cancer Agents in Medicinal Chemistry Contribution of Efflux Pump Activity to the Delivery of Pulmonary Therapeutics
Current Drug Metabolism Preventive and Therapeutic Role of Muscle Contraction Against Chronic Diseases
Current Pharmaceutical Design WISP1 (CCN4) Autoregulates its Expression and Nuclear Trafficking of β-Catenin during Oxidant Stress with Limited Effects upon Neuronal Autophagy
Current Neurovascular Research Omega-3 Polyunsaturated Fatty Acids and Depression: A Review of the Evidence
Current Pharmaceutical Design Understanding Autophagy in Cell Death Control
Current Pharmaceutical Design Synthesis, Biological Evaluation and Docking Studies of 1,3,4-Oxadiazole Fused Benzothiazole Derivatives for Anticancer Drugs
Letters in Drug Design & Discovery Development and Pharmacological Evaluation of a PEG Based Nanoparticulate Camptothecin Analog for Oral Administration
Current Drug Delivery Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice
Current Cancer Drug Targets The Nitric Oxide Prodrug JS-K and Its Structural Analogues as Cancer Therapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry